Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohamed Ibrahim Mohamed Fahmy"'
Autor:
Ahmed El-Masry, Hosny Mohamed1, Mohamed Ibrahim, Mohamed Fahmy1, Fathallah Elsayed, Mohamed Fathallah1 abuyosefmohamed@yahoo.com
Publikováno v:
Egyptian Journal of Hospital Medicine. Spring2021, Vol. 83 Issue 1, p1208-1214. 7p.
Autor:
Mohamed Ibrahim Mohamed, Fahmy, Rabab Hamed, Sayed, Muhammad Farag, El-Yamany, Reham, El-Naggar, Hesham, A Eliwa
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 153
The prevalence of metabolic syndrome (MetS) has been rising alarmingly and it has now become a global concern causing an enormous economic burden on the health care system. MetS is generally linked to complications in lipid metabolism, oxidative stre
Autor:
Muhammad Y. Al-Shorbagy, Naglaa Assaf, Muhammad Abd El-Latif Saad, Mohamed Ibrahim Mohamed Fahmy, Muhammad Farag El-Yamany, Ahmed Abd El-Aziz Hegazy
Publikováno v:
Inflammation. 43:401-416
Ischemic stroke is a major cause of death and motor disabilities all over the world. It is a muti-factorial disorder associated with inflammatory, apoptotic, and oxidative responses. Nateglinide (NAT), an insulinotropic agent used for the treatment o
Autor:
Mohamed Ibrahim Mohamed Fahmy, Rabab Hamed Sayed, Muhammad Farag El-Yamany, Reham El-Naggar, Hesham A. Eliwa
Publikováno v:
Biomedicine & Pharmacotherapy. 153:113526
Autor:
Ahmed Abd El-Aziz Hegazy, Muhammad Y. Al-Shorbagy, Mohamed Ibrahim Mohamed Fahmy, Reham Abdelrahman Elnaggar, Muhammad Farag El-Yamany, Muhammad Abd El-Latif Saad, Rabab H. Sayed
Publikováno v:
Journal of biochemical and molecular toxicologyREFERENCES. 35(7)
Eprosartan (EPRO), an angiotensin receptor type-1 (AT-1) blocker, exhibited neuroprotective activities in ischemic stroke resulting from focal cerebral ischemia in rats. The current study aimed to clarify the neuroprotective role of EPRO in middle ca